110 2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities SASB index SASB Disclosure Disclosure requirement Response or disclosure location HC-MS-250a.1 Number of recalls issued, total units recalled Product Impact – Product safety HC-MS-250a.2 List of products listed in the FDA’s MedWatch Safety Alerts for Human Medical Products database Product Impact – Product safety HC-MS-250a.3 Number of fatalities related to products as reported in the FDA Manufacturer and User Facility Device Experience Product Impact – Product safety HC-MS-250a.4 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMPs), by type Product Impact – Product safety HC-MS-270a.1 Total amount of monetary losses as a result of legal proceedings associated with false marketing claims While we have implemented, and continue to improve upon, programs and management systems around product marketing, we may, on occasion, be subject to legal actions. For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings. HC-MS-270a.2 Description of code of ethics governing promotion of off-label use of products Transparency – Ethics in sales and marketing HC-MS-410a.1 Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable products Product Impact – 2030+ commitments; Management of materials of concern HC-MS-410a.2 Total amount of products accepted for takeback and reused, recycled or donated, broken down by (1) devices and equipment and (2) supplies Product Impact – Product takeback Healthy workforce & Communities – Healthy communities SASB Disclosure Disclosure requirement Response or disclosure location HC-MS-430a.1 Percentage of (1) entity’s facilities and (2) Tier I suppliers’ facilities participating in third- party audit programs for manufacturing and product quality 95 percent of manufacturing sites and 91 percent of design centers have quality management systems externally certified to either ISO 13485, ISO 9001or ISO 17025. These locations will receive audits of their management systems as part of the ongoing certification process. Supplier quality audits are carried out by an internal BD team using a risk-based approach determined by the goods or service. Supplier quality audits are part of a comprehensive supplier management approach that also includes monitoring of key metrics and supplier corrective action as required. Product Impact – Product safety HC-MS-430a.2 Description of efforts to maintain traceability within the distribution chain BD has implemented a series of procedures and technology solutions to ensure end-to-end identification and traceability of materials and products throughout the supply chain. Our procedures describe assignment of stock keeping unit (SKU) level material, product and batch unique identifiers, as well as how these identifiers are managed within our enterprise resource planning (ERP) systems. These traceability and identification principles also include BD’s purchased finished goods. Traceability is maintained throughout all stages of manufacturing, storage and distribution, from receipt through and including installation, return and repair (where applicable). Additionally, BD has acquired and deployed a control tower solution which monitors and tracks real-time shipments across ocean, air and ground to internal and customer ship-to addresses. HC-MS-430a.3 Description of the management of risks associated with the use of critical materials Responsible Supply Chain – Responsible sourcing HC-MS-510a.1 Total amount of monetary losses as a result of legal proceedings associated with bribery or corruption While we have implemented, and continue to improve upon, programs and management systems around ethics and compliance, we may, on occasion, be subject to legal actions. For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings. For further information about antibribery and anticorruption, see Transparency – Ethics and compliance. HC-MS-510a.2 Description of code of ethics governing interactions with healthcare professionals Transparency – Ethics in sales and marketing